SOCRA EXAM PREP WITH ACCURATE
SOLUTIONS GRADED A+
1. Which of the following is a disclosure of financial interests form?
A. FDA Form 3454
B. FDA Form 3455 ✅
C. FDA Form 1571
D. FDA Form 3500
Answer: B. FDA Form 3455
Explanation: FDA Form 3455 is used by investigators to disclose any
financial arrangements that could present a conflict of interest in clinical
trials. This ensures transparency and protects the integrity of the research.
2. Which of the following is a certification of financial interest form?
A. FDA Form 3454 ✅
B. FDA Form 3455
C. FDA Form 1571
D. FDA Form 3500
Answer: A. FDA Form 3454
Explanation: Form 3454 certifies that the investigator has no financial
interests that could affect the study outcome. It is submitted to confirm the
absence of conflicts of interest.
3. If the investigator did have financial arrangements with the
sponsor, he/she would submit which form?
A. FDA Form 3454
B. FDA Form 3455 ✅
C. FDA Form 1571
D. FDA Form 3500
Answer: B. FDA Form 3455
Explanation: Form 3455 discloses financial interests when an investigator
has arrangements that might affect the study. This helps the FDA assess
potential bias in clinical research.
4. This form is submitted by the sponsor to the FDA prior to the
beginning of the drug trial:
,A. FDA Form 3454
B. FDA Form 3455
C. Investigational New Drug Application (IND 1571) ✅
D. FDA Form 3500
Answer: C. Investigational New Drug Application (1571)
Explanation: The IND application is the official request to FDA to begin
clinical trials of a new drug in humans. It contains preclinical data, protocols,
and investigator information.
5. The OMB number in the top right corner of FDA forms stands for:
A. Office of Management and Budget ✅
B. Office of Medical Bureau
C. Official Management of Biologics
D. Office of Medicinal Budget
Answer: A. Office of Management and Budget
Explanation: The OMB number is a unique identifier assigned by the Office
of Management and Budget for forms submitted to federal agencies. It
ensures standardized review and approval of information collection.
6. The form submitted to the FDA to report an adverse event is:
A. FDA Form 3454
B. FDA Form 3455
C. FDA Form 3500 ✅
D. FDA Form 1571
Answer: C. 3500
Explanation: FDA Form 3500 is used to report adverse drug events, helping
the FDA monitor the safety of drugs after they are marketed or in trials.
Accurate reporting is essential for patient safety.
7. Medical device adverse events/problems are reported via:
A. FDA Form 3500
B. FDA Form 3500A ✅
C. FDA Form 1571
D. FDA Form 3455
Answer: B. 3500A
Explanation: Form 3500A is specific for medical device adverse events. It
allows manufacturers and user facilities to report problems that could affect
the safety or effectiveness of a device.
,8. FDA Form 1571 is:
A. A disclosure of financial interests
B. A cover sheet for Investigational New Drug Applications ✅
C. An adverse event report
D. A post-marketing safety report
Answer: B. Cover-sheet for IND applications
Explanation: Form 1571 serves as the official cover sheet for submitting an
IND. It contains basic information about the investigational drug, sponsor,
and clinical trial plan.
9. 21 CFR 312 deals with:
A. Good Laboratory Practices
B. Investigational New Drug Application ✅
C. Human Subject Protection
D. Medical Device Safety
Answer: B. Investigational New Drug Application
Explanation: 21 CFR 312 regulates the submission, review, and conduct of
INDs, including requirements for safety, protocols, and reporting.
10. Investigational new drug means:
A. A generic drug under review
B. A new drug or biological drug used in a clinical investigation ✅
C. Any marketed drug
D. A compound for animal studies only
Answer: B. A new drug or biological drug used in a clinical investigation
Explanation: An investigational new drug is one that is not yet approved for
general use in humans and is under study in clinical trials for safety and
efficacy.
11. The immediate package of an investigational new drug intended
for human use must bear the statement:
A. “For Laboratory Use Only”
B. “Caution: New Drug—Limited by Federal (or United States) law to
investigational use.” ✅
C. “Prescription Only”
D. “FDA Approved”
Answer: B. “Caution: New Drug—Limited by Federal (or United States) law
to investigational use.”
Explanation: This labeling alerts clinical trial participants and healthcare
, providers that the drug is investigational and not yet approved for general
use.
12. Which of the following is NOT listed on FDA Form 1571?
A. Protocol information
B. Investigator information
C. Approved informed consent document ✅
D. Sponsor information
Answer: C. Approved informed consent document
Explanation: FDA Form 1571 collects information about the sponsor,
investigators, and the protocol, but the consent form itself is submitted
separately for IRB approval.
13. “Any adverse drug experience that places the patient or subject,
in the view of the investigator, at immediate risk of death from the
reaction as it occurred” is:
A. Severe adverse event
B. Life-threatening adverse drug experience ✅
C. Unexpected adverse event
D. Common side effect
Answer: B. Life-threatening adverse drug experience
Explanation: Life-threatening adverse events are those that pose
immediate danger to life. Timely reporting is critical to protect patients in
clinical trials.
14. The three main ethical principles of the Belmont Report are:
A. Autonomy, Beneficence, Confidentiality
B. Respect for Persons, Beneficence, Justice ✅
C. Informed Consent, Risk Assessment, Privacy
D. Safety, Efficacy, Compliance
Answer: B. Respect for Persons, Beneficence, Justice
Explanation: The Belmont Report establishes these principles to guide
ethical research involving human subjects, ensuring protection, fairness, and
informed decision-making.
15. Applications of the Belmont Report include:
A. Safety testing, Efficacy analysis, Market approval
B. Informed consent, Assessment of risks and benefits, Selection of subjects
✅
SOLUTIONS GRADED A+
1. Which of the following is a disclosure of financial interests form?
A. FDA Form 3454
B. FDA Form 3455 ✅
C. FDA Form 1571
D. FDA Form 3500
Answer: B. FDA Form 3455
Explanation: FDA Form 3455 is used by investigators to disclose any
financial arrangements that could present a conflict of interest in clinical
trials. This ensures transparency and protects the integrity of the research.
2. Which of the following is a certification of financial interest form?
A. FDA Form 3454 ✅
B. FDA Form 3455
C. FDA Form 1571
D. FDA Form 3500
Answer: A. FDA Form 3454
Explanation: Form 3454 certifies that the investigator has no financial
interests that could affect the study outcome. It is submitted to confirm the
absence of conflicts of interest.
3. If the investigator did have financial arrangements with the
sponsor, he/she would submit which form?
A. FDA Form 3454
B. FDA Form 3455 ✅
C. FDA Form 1571
D. FDA Form 3500
Answer: B. FDA Form 3455
Explanation: Form 3455 discloses financial interests when an investigator
has arrangements that might affect the study. This helps the FDA assess
potential bias in clinical research.
4. This form is submitted by the sponsor to the FDA prior to the
beginning of the drug trial:
,A. FDA Form 3454
B. FDA Form 3455
C. Investigational New Drug Application (IND 1571) ✅
D. FDA Form 3500
Answer: C. Investigational New Drug Application (1571)
Explanation: The IND application is the official request to FDA to begin
clinical trials of a new drug in humans. It contains preclinical data, protocols,
and investigator information.
5. The OMB number in the top right corner of FDA forms stands for:
A. Office of Management and Budget ✅
B. Office of Medical Bureau
C. Official Management of Biologics
D. Office of Medicinal Budget
Answer: A. Office of Management and Budget
Explanation: The OMB number is a unique identifier assigned by the Office
of Management and Budget for forms submitted to federal agencies. It
ensures standardized review and approval of information collection.
6. The form submitted to the FDA to report an adverse event is:
A. FDA Form 3454
B. FDA Form 3455
C. FDA Form 3500 ✅
D. FDA Form 1571
Answer: C. 3500
Explanation: FDA Form 3500 is used to report adverse drug events, helping
the FDA monitor the safety of drugs after they are marketed or in trials.
Accurate reporting is essential for patient safety.
7. Medical device adverse events/problems are reported via:
A. FDA Form 3500
B. FDA Form 3500A ✅
C. FDA Form 1571
D. FDA Form 3455
Answer: B. 3500A
Explanation: Form 3500A is specific for medical device adverse events. It
allows manufacturers and user facilities to report problems that could affect
the safety or effectiveness of a device.
,8. FDA Form 1571 is:
A. A disclosure of financial interests
B. A cover sheet for Investigational New Drug Applications ✅
C. An adverse event report
D. A post-marketing safety report
Answer: B. Cover-sheet for IND applications
Explanation: Form 1571 serves as the official cover sheet for submitting an
IND. It contains basic information about the investigational drug, sponsor,
and clinical trial plan.
9. 21 CFR 312 deals with:
A. Good Laboratory Practices
B. Investigational New Drug Application ✅
C. Human Subject Protection
D. Medical Device Safety
Answer: B. Investigational New Drug Application
Explanation: 21 CFR 312 regulates the submission, review, and conduct of
INDs, including requirements for safety, protocols, and reporting.
10. Investigational new drug means:
A. A generic drug under review
B. A new drug or biological drug used in a clinical investigation ✅
C. Any marketed drug
D. A compound for animal studies only
Answer: B. A new drug or biological drug used in a clinical investigation
Explanation: An investigational new drug is one that is not yet approved for
general use in humans and is under study in clinical trials for safety and
efficacy.
11. The immediate package of an investigational new drug intended
for human use must bear the statement:
A. “For Laboratory Use Only”
B. “Caution: New Drug—Limited by Federal (or United States) law to
investigational use.” ✅
C. “Prescription Only”
D. “FDA Approved”
Answer: B. “Caution: New Drug—Limited by Federal (or United States) law
to investigational use.”
Explanation: This labeling alerts clinical trial participants and healthcare
, providers that the drug is investigational and not yet approved for general
use.
12. Which of the following is NOT listed on FDA Form 1571?
A. Protocol information
B. Investigator information
C. Approved informed consent document ✅
D. Sponsor information
Answer: C. Approved informed consent document
Explanation: FDA Form 1571 collects information about the sponsor,
investigators, and the protocol, but the consent form itself is submitted
separately for IRB approval.
13. “Any adverse drug experience that places the patient or subject,
in the view of the investigator, at immediate risk of death from the
reaction as it occurred” is:
A. Severe adverse event
B. Life-threatening adverse drug experience ✅
C. Unexpected adverse event
D. Common side effect
Answer: B. Life-threatening adverse drug experience
Explanation: Life-threatening adverse events are those that pose
immediate danger to life. Timely reporting is critical to protect patients in
clinical trials.
14. The three main ethical principles of the Belmont Report are:
A. Autonomy, Beneficence, Confidentiality
B. Respect for Persons, Beneficence, Justice ✅
C. Informed Consent, Risk Assessment, Privacy
D. Safety, Efficacy, Compliance
Answer: B. Respect for Persons, Beneficence, Justice
Explanation: The Belmont Report establishes these principles to guide
ethical research involving human subjects, ensuring protection, fairness, and
informed decision-making.
15. Applications of the Belmont Report include:
A. Safety testing, Efficacy analysis, Market approval
B. Informed consent, Assessment of risks and benefits, Selection of subjects
✅
